NERIX Performance — Neuberger Berman Emerging Markets Debt Fund, Institutional Class
Data updated: 2025-09-24
NERIX returned +10.13% over one year to Jul 2025. Annualised returns are +8.70% over 3 years and +1.75% over 5 years. The fund beat its Emerging Markets Bond category average: $100 invested three years ago grew to $128, against $125 for the category, and to $110 over one year, against $109. Volatility over the past three years was 8.83% a year. In the 12 months to Jul 2025 the fund lost a net $56.9M, and assets reached $100.89M.
NERIX Growth of $100
What $100 invested in Neuberger Berman Emerging Markets Debt Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Bond category average over the same months.
| Period | NERIX | Category average |
|---|---|---|
| 1 year (Aug 2024 – Jul 2025) | $110 | $109 |
| 3 years (Aug 2022 – Jul 2025) | $128 | $125 |
| 5 years (Aug 2020 – Jul 2025) | $109 | $111 |
| Since data start (Aug 2019 – Jul 2025) | $111 | $113 |
NERIX Trailing Returns
Total returns to Jul 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +10.13% |
| 3 years (annualised) | +8.70% |
| 5 years (annualised) | +1.75% |
NERIX Annual Returns
Calendar-year total returns of Neuberger Berman Emerging Markets Debt Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jul) | +8.77% |
| 2024 | +2.89% |
| 2023 | +12.02% |
| 2022 | −13.43% |
| 2021 | −5.75% |
| 2020 | +4.68% |
| 2019 (Aug–Dec) | +3.42% |
NERIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +2.0% | +1.0% | +0.4% | +1.3% | +1.4% | +3.1% | −0.7% | — | — | — | — | — |
| 2024 | −0.9% | +0.4% | +0.8% | −2.0% | +1.7% | −0.5% | +2.2% | +2.5% | +2.8% | −2.9% | +0.4% | −1.4% |
| 2023 | +4.3% | −3.1% | +2.5% | +0.7% | −1.2% | +3.0% | +2.0% | −1.8% | −3.0% | −0.7% | +5.2% | +4.1% |
| 2022 | −1.4% | −4.9% | −1.0% | −4.9% | +0.7% | −6.0% | +1.1% | −0.1% | −5.4% | −0.5% | +7.2% | +1.5% |
| 2021 | −1.2% | −1.7% | −2.2% | +2.0% | +1.9% | −0.2% | −0.5% | +1.1% | −2.5% | −1.1% | −2.6% | +1.4% |
| 2020 | −0.2% | −2.1% | −14.2% | +3.6% | +7.2% | +2.0% | +3.5% | +0.7% | −2.3% | 0.0% | +5.1% | +3.1% |
| 2019 | — | — | — | — | — | — | — | −2.2% | +0.8% | +2.0% | −0.9% | +3.8% |
NERIX Risk
Risk measures from monthly returns over Aug 2022 – Jul 2025.
- 3-year volatility (annualised): 8.83%
- 3-year Sharpe ratio: 0.48 (vs 4.5% risk-free rate)
- Best month: +7.20% (Nov 2022)
- Worst month: −5.37% (Sep 2022)
NERIX Fund Flows
Monthly money in and out of Neuberger Berman Emerging Markets Debt Fund, from SEC Form N-PORT.
- 12-month net flow: −$56.9M
- 12-month gross sales (incl. reinvestments): $26.1M
- Sales ÷ redemptions: 0.31×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2025 | $3.2M | $8.2M | −$4.9M |
| Jun 2025 | $1.7M | $3.6M | −$1.9M |
| May 2025 | $2.4M | $10.3M | −$7.9M |
| Apr 2025 | $1.8M | $14.8M | −$13.0M |
| Mar 2025 | $1.5M | $14.9M | −$13.4M |
| Feb 2025 | $2.6M | $5.8M | −$3.2M |
| Jan 2025 | $1.7M | $3.0M | −$1.3M |
| Dec 2024 | $1.4M | $6.3M | −$4.9M |
| Nov 2024 | $3.1M | $1.9M | $1.2M |
| Oct 2024 | $3.7M | $741K | $3.0M |
| Sep 2024 | $1.4M | $953K | $437K |
| Aug 2024 | $1.6M | $12.5M | −$11.0M |
NERIX Assets Under Management
Net assets of Neuberger Berman Emerging Markets Debt Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-07-31 | $100.89M |
| 2025-04-30 | $112.81M |
| 2025-01-31 | $141.06M |
| 2024-10-31 | $147.14M |
| 2024-07-31 | $154.01M |
| 2024-04-30 | $150.98M |
| 2024-01-31 | $153.29M |
| 2023-10-31 | $142.34M |
| 2023-07-31 | $147.38M |
| 2023-04-30 | $134.53M |
| 2023-01-31 | $128.77M |
| 2022-10-31 | $104.86M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.